**About the Editors**

#### **Rosal´ıa Rodr´ıguez-Rodr´ıguez**

Rosalia Rodriguez-Rodriguez has a PhD in Pharmacology and is an established researcher, associate Professor, co-IP of the Neurolipid Group, and Head of Biomedicine at UIC Barcelona. She has more than 15 years of research expertise in the study of obesity and related complications in cellular and animal models at national and international institutions (Aarhus University, Oxford University, University of Bath). Her current research involves the study of the molecular mechanisms in the hypothalamus underlying obesity and the generation of drug delivery systems based in nanomedicines to target brain cells and manage obesity. She has been the PI of 5 national/international research projects and has participated in more than 15 scientific projects, and in all of them, she has shown passion for and commitment to the project's progression and future steps. She has 2 international patents (1 exploited), has authored 67 publications (H index 28), has supervised 9 predoctoral students, and is the associate journal Editor and Expert Evaluator of national and international research institutions.

#### **Cristina Miralpeix**

Dr Cristina Miralpeix gained a PhD in Biomedicine in 2019 and is currently a postdoctoral researcher in the Energy Balance and Obesity group led by Dr Daniela Cota at Neurocentre Magendie. Her main interest is the development of obesity and the crosstalk between peripheral metabolism and brain circuits. She has particular interest and expertise in the neuronal pathways that regulate feeding behaviour in animal models of obesity and also in the endocannabinoid system. She has been awarded several grants, one of them being a postdoc grant from the Fondation Recherche Medical for ´ 3 years.
